E
Telesis Bio, Inc. TBIO
$0.30 $0.000.00%
Recommendation
Sell
Prev Close
$0.30
Volume
646
Avg Vol (90D)
5,680
Market Cap
$532.75K
Dividend & Yield
--
52-Week Range
$0.25 - $10.62
P/E (TTM)
--
EPS (TTM)
-$28.19
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Telesis Bio, Inc. (NASDAQ:TBIO) Short Interest Update
9/27/2024 - Ticker Report
What's Going On With Telesis Bio Shares Thursday?
9/26/2024 - Benzinga
Telesis Bio partners with Danaher company Beckman Coulter
9/26/2024 - Seeking Alpha - Healthcare
Telesis Bio Stock Is Soaring Wednesday: What's Going On?
9/25/2024 - Benzinga
Telesis Bio and Beckman Coulter team to enable 'breakthrough' discoveries
9/25/2024 - TipRanks Financial Blog
Telesis Bio and Beckman Coulter team to enable 'breakthrough' discoveries
9/25/2024 - The Fly
Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
9/25/2024 - Globe Newswire
Telesis Bio to delist its securities from Nasdaq
9/10/2024 - Seeking Alpha - Healthcare
Telesis Bio to delist its securities from Nasdaq
9/10/2024 - SeekingAlpha.com: All News
Telesis Bio to delist shares from Nasdaq
9/10/2024 - The Fly
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
9/10/2024 - Globe Newswire
Telesis Bio (NASDAQ:TBIO) Stock Price Up 3.8%
9/5/2024 - Ticker Report
Telesis Bio Board Shake-Up: New Chair, Committee Restructuring
8/30/2024 - TipRanks Financial Blog
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q2 2024
8/8/2024 - InvestorPlace
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
8/7/2024 - Globe Newswire
Telesis Bio, Inc. (NASDAQ:TBIO) Short Interest Down 24.3% in June
7/15/2024 - Ticker Report
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
7/11/2024 - InvestorPlace
Telesis Bio, Inc. (NASDAQ:TBIO) Short Interest Update
6/15/2024 - Zolmax
Telesis Bio in Jeopardy: Risks of Nasdaq Delisting and Financial Instability Loom
5/11/2024 - TipRanks Financial Blog
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q1 2024
5/10/2024 - InvestorPlace
Telesis Bio Reports First Quarter 2024 Financial Results
5/9/2024 - Globe Newswire
Telesis Bio Announces Reverse Stock Split
5/6/2024 - Globe Newswire
Telesis Bio announces leadership transition amid new commercial focus
4/18/2024 - SeekingAlpha.com: All News
Telesis Bio announces leadership transition amid new commercial focus
4/18/2024 - Seeking Alpha - Healthcare
Telesis Bio Leadership Shake-Up and Board Expansion
4/18/2024 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$12.28M
EBITDA (TTM)
-$27.32M
EBIT (TTM)
-$29.50M
Net Income (TTM)
-$45.55M
Balance Sheet
Total Assets (Q)
$24.74M
Total Debt (Q)
$16.29M
Total Liabilities (Q)
$20.86M
Book Value Per Share (Q)
-$15.35
Cash Flow
Cash from Operations (TTM)
-$17.51M
Cash from Investing (TTM)
$23.19M
Cash from Financing (TTM)
-$15.22M
Net Change in Cash (TTM)
-$9.52M
Filings
Filing Date
Thursday, November 7, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 24 and 28 (est)
Price History
Loading...
Beta
1.92
7-Day Total Return
-28.57%
30-Day Total Return
7.14%
60-Day Total Return
-34.63%
90-Day Total Return
-80.65%
Year to Date Total Return
-25.00%
1-Year Total Return
-96.93%
2-Year Total Return
-99.24%
3-Year Total Return
-99.82%
5-Year Total Return
--
52-week Low
Jan 06, 2025 - $0.25
52-week High
Mar 12, 2024 - $10.62
Valuation
Market Cap
$532.75K - Nano Cap
Enterprise Value
$43.41M
Price/Sales (TTM)
0.04
Price/Book (Q)
-0.02
Dividends and Shares
Shares Outstanding
1.77M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
telesisbio.com
Phone Number
858 228 4115
Address
10431 Wateridge Circle
San Diego, CA 92121-2993
Country
United States
Year Founded
2011
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and... more
OTC PK 03/12/2025 9:30AM Eastern Quotes delayed
Weiss Ratings